- Home
- BTA vs AMLX Comparison
BTA vs AMLX Comparison
Compare BTA & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTA
- AMLX
- Stock Information
- Founded
- BTA 2006
- AMLX 2014
- Country
- BTA United States
- AMLX United States
- Employees
- BTA N/A
- AMLX N/A
- Industry
- BTA Trusts Except Educational Religious and Charitable
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- BTA Finance
- AMLX Health Care
- Exchange
- BTA Nasdaq
- AMLX Nasdaq
- Market Cap
- BTA N/A
- AMLX 134.0M
- IPO Year
- BTA N/A
- AMLX 2022
- Fundamental
- Price
- BTA $10.53
- AMLX $3.92
- Analyst Decision
- BTA
- AMLX Buy
- Analyst Count
- BTA 0
- AMLX 7
- Target Price
- BTA N/A
- AMLX $5.20
- AVG Volume (30 Days)
- BTA 21.9K
- AMLX 1.4M
- Earning Date
- BTA 01-01-0001
- AMLX 11-07-2024
- Dividend Yield
- BTA 5.22%
- AMLX N/A
- EPS Growth
- BTA N/A
- AMLX N/A
- EPS
- BTA N/A
- AMLX N/A
- Revenue
- BTA N/A
- AMLX $298,762,000.00
- Revenue This Year
- BTA N/A
- AMLX N/A
- Revenue Next Year
- BTA N/A
- AMLX $149.49
- P/E Ratio
- BTA N/A
- AMLX N/A
- Revenue Growth
- BTA N/A
- AMLX 55.71
- 52 Week Low
- BTA $8.59
- AMLX $1.58
- 52 Week High
- BTA $10.62
- AMLX $19.95
- Technical
- Relative Strength Index (RSI)
- BTA 40.95
- AMLX 72.38
- Support Level
- BTA $10.47
- AMLX $3.42
- Resistance Level
- BTA $10.66
- AMLX $3.48
- Average True Range (ATR)
- BTA 0.06
- AMLX 0.28
- MACD
- BTA -0.02
- AMLX 0.06
- Stochastic Oscillator
- BTA 18.18
- AMLX 65.16
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder.